Trial
NCT00555217
VA NEPHRON-D: Diabetes iN Nephropathy Study
Phase IIITERMINATEDSAFETYConfidence: HIGH
Sponsor
US Department of Veterans Affairs
Collaborators
—
Condition
Kidney Disease
Intervention
losartan
Why stopped
It was stopped primarily because of safety concerns along with low conditional power to detect a treatment effect on the primary outcome.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-05-29